Performance of Long-wavelength Autofluorescence Imaging

NACompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

April 9, 2024

Study Completion Date

April 9, 2024

Conditions
Retinal DiseaseRetinal DegenerationRetinal Dystrophies
Interventions
DEVICE

Long-wavelength autofluorescence imaging

Long-wavelength autofluorescence imaging will be performed with a prototype confocal scanning laser (cSLO) ophthalmoscope which will be equipped with additional laser sources and a reference for quantification of the signal. The experimental long-wavelength laser sources will be integrated into a custom-modified Spectralis HRA cSLO from Heidelberg Engineering. The additional laser sources will operate with long wavelength which are less energetic compared to the conventional short-wavelength lasers used currently for routine autofluorescence imaging. All safety standards have been considered and the light exposure for all imaging modes is well below the exposure limits for Class 1 and Class1M laser products as defined in the standard IEC 60825-1, edition 3.0, 2014-5.

Trial Locations (1)

OX3 9DU

Oxford Eye Hospital, Oxford

All Listed Sponsors
lead

Oxford University Hospitals NHS Trust

OTHER

NCT03592017 - Performance of Long-wavelength Autofluorescence Imaging | Biotech Hunter | Biotech Hunter